Literature DB >> 1558199

Minimal compartmental model of circulatory mixing of indocyanine green.

T K Henthorn1, M J Avram, T C Krejcie, C A Shanks, A Asada, D A Kaczynski.   

Abstract

A model of indocyanine green (ICG) disposition from the moment of its injection in blood was developed. ICG disposition was characterized in five dogs deeply anesthetized with halothane, which decreased cardiac output and prolonged intravascular mixing. After ICG injection into the right atrium, femoral arterial blood samples were collected every 3 s for the 1st min and less frequently to 20 min. ICG concentrations were measured by high-performance liquid chromatography and modeled with SAAM 30.1. A fully identifiable recirculatory compartmental model with time delays was used to describe ICG disposition. The central blood volume averaged 23.4 ml/kg, and total blood volume averaged 78.9 ml/kg. Fifty-three percent of the cardiac output flowed through 14% of the peripheral blood volume while the remaining 47% flowed through 86% of the peripheral volume. This new model is isomorphic with a parallel channel, lumped-parameter circulation model and provides more information than stochastic, noncompartmental recirculatory pharmacokinetic techniques. This intravascular mixing model can be applied to determine the contribution of the circulation to drug distribution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558199     DOI: 10.1152/ajpheart.1992.262.3.H903

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Do plasma concentrations obtained from early arterial blood sampling improve pharmacokinetic/pharmacodynamic modeling?

Authors:  T M Beaufort; J H Proost; K Kuizenga; M C Houwertjes; U W Kleef; J M Wierda
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

2.  A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.

Authors:  R E Oliver; A F Jones; M Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

Review 3.  [Modern concepts in pharmacokinetics of intravenous anesthetics].

Authors:  T Heidegger; C F Minto; T W Schnider
Journal:  Anaesthesist       Date:  2004-01       Impact factor: 1.041

Review 4.  [Target-controlled infusion. Clinical relevance and special features when using pharmacokinetic models].

Authors:  H Ihmsen; S Schraag; S Kreuer; J Bruhn; S Albrecht
Journal:  Anaesthesist       Date:  2009-07       Impact factor: 1.041

5.  A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium.

Authors:  V Nigrovic; J Gaspari; M Banoub
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

6.  A recirculatory model of the pulmonary uptake and pharmacokinetics of lidocaine based on analysis of arterial and mixed venous data from dogs.

Authors:  T C Krejcie; M J Avram; W B Gentry; C U Niemann; M P Janowski; T K Henthorn
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

Review 7.  State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development.

Authors:  Venkata Yellepeddi; Joseph Rower; Xiaoxi Liu; Shaun Kumar; Jahidur Rashid; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 6.447

8.  Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs.

Authors:  T C Krejcie; J A Jacquez; M J Avram; C U Niemann; C A Shanks; T K Henthorn
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

9.  Assessing the utility of the utility function.

Authors:  Evan D Kharasch; Carl E Rosow
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

10.  A pharmacokinetic-pharmacodynamic model for quantal responses with thiopental.

Authors:  C A Shanks; M J Avram; T C Krejcie; T K Henthorn; W B Gentry
Journal:  J Pharmacokinet Biopharm       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.